KenvueKVUEEarnings & Financial Report
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
KVUE Q3 2025 Key Financial Metrics
Revenue
$3.8B
Gross Profit
$2.2B
Operating Profit
$629.0M
Net Profit
$398.0M
Gross Margin
59.1%
Operating Margin
16.7%
Net Margin
10.6%
YoY Growth
-3.5%
EPS
$0.21
Financial Flow
Kenvue Q3 2025 Financial Summary
Kenvue reported revenue of $3.8B for Q3 2025, with a net profit of $398.0M (10.6% margin). Cost of goods sold was $1.5B, operating expenses totaled $1.6B.
Key Financial Metrics
| Total Revenue | $3.8B |
|---|---|
| Net Profit | $398.0M |
| Gross Margin | 59.1% |
| Operating Margin | 16.7% |
| Report Period | Q3 2025 |
Kenvue Annual Revenue by Year
Kenvue annual revenue history includes year-by-year totals (for example, 2024 revenue was $15.5B).
| Year | Annual Revenue |
|---|---|
| 2024 | $15.5B |
| 2023 | $15.5B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.92B | $3.89B | $4.00B | $3.90B | $3.66B | $3.74B | $3.84B | $3.76B |
| YoY Growth | 3.3% | 3.4% | 3.8% | -2.8% | -6.5% | -3.9% | -4.0% | -3.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $27.08B | $27.28B | $26.44B | $26.93B | $25.60B | $26.26B | $27.13B | $27.25B |
| Liabilities | $16.18B | $16.66B | $16.27B | $16.28B | $15.93B | $16.20B | $16.40B | $16.61B |
| Equity | $10.89B | $10.62B | $10.18B | $10.64B | $9.67B | $10.05B | $10.73B | $10.63B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $950.0M | $287.0M | $440.0M | $249.0M | $793.0M | $428.0M | $621.0M | $294.0M |
Other Consumer Staples Companies
EL
Estée Lauder Companies (The)
Revenue
$4.2B
Net Profit
$162.0M
PG
Procter & Gamble
Revenue
$22.2B
Net Profit
$4.3B
MO
Altria
Revenue
$6.1B
Net Profit
$2.4B
ADM
Archer Daniels Midland
Revenue
$6.4B
Net Profit
$108.0M
BF.B
Brown–Forman
Revenue
$1.0B
Net Profit
$224.0M
BG
Bunge Global
Revenue
$4.9B
Net Profit
$95.0M
CPB
Campbell's Company (The)
Revenue
$2.7B
Net Profit
$194.0M
CHD
Church & Dwight
Revenue
$1.6B
Net Profit
$143.5M
CLX
Clorox
Revenue
$1.7B
Net Profit
$157.0M
KO
Coca-Cola Company (The)
Revenue
$12.5B
Net Profit
$3.7B